A couple Saturday thoughts from reading the past day of posts:
1- could it be possible, CTIX is in close negotiations for B-Absssi partnership? That is why they backed off?
2- back to the future! We have come full circle back to P. Does MGMT really feel P has a chance for 1-2 billion a year? Dr J leaves and Dr. B enters. I think their backgrounds can tell us everything on where our current focus is.
3- Kevetrin trial will bring a huge crowd this year of new shareholders. This next combo trial will be our legacy. IMO.